Evidence map›Paper›PMID 26465937›Full record

ArticlePLoS genetics2015

Regulation of Clostridium difficile Spore Formation by the SpoIIQ and SpoIIIA Proteins.

Kelly A Fimlaid, Owen Jensen, M Lauren Donnelly, M Sloan Siegrist, Aimee Shen

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Clostridioides difficile Sporulation.Advances in experimental medicine and biology · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Preventive Effects ofInternational journal of molecular sciences · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. SpoIVA-SipL Complex Formation Is Essential forJournal of bacteriology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kelly A FimlaidDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America; Program in Cellular, Molecular & Biomedical Sciences, University of Vermont, Burlington, Vermont, United States of America.
Owen JensenDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America.
M Lauren DonnellyDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America.
M Sloan SiegristDepartment of Microbiology, University of Massachusetts Amherst, Amherst, Massachusetts, United States of America.
Aimee ShenDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America.
University of Vermont · USUniversity of Massachusetts Amherst · US

Funding

VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MATRAJT, MARIANA L · 2006 to 2011
$14.5M
Vermont Immunobioloigy/ Infectious Diseases CenterP20GM103496 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2012 to 2015
$8.7M
Spore Assembly in Clostridium DifficileR01AI122232 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SHEN, AIMEE · 2016 to 2025
$4.2M
Vermont Immunology/Infectious Diseases Training GrantT32AI055402 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GARY E WARD · 2005 to 2026
$2.7M
Cell Division in ClostridioidesdifficileR37AI122232 · NIAID · TUFTS UNIVERSITY BOSTON · PI Aimee Shen · 2026 to 2026
$509k
NCRR NIH HHS P20 RR021905NIAID NIH HHS R01 AI122232NIAID NIH HHS R37 AI122232NIAID NIH HHS T32 AI055402NIGMS NIH HHS P20 GM103496
6 · The paper itself

Abstract

Sporulation is an ancient developmental process that involves the formation of a highly resistant endospore within a larger mother cell. In the model organism Bacillus subtilis, sporulation-specific sigma factors activate compartment-specific transcriptional programs that drive spore morphogenesis. σG activity in the forespore depends on the formation of a secretion complex, known as the "feeding tube," that bridges the mother cell and forespore and maintains forespore integrity. Even though these channel components are conserved in all spore formers, recent studies in the major nosocomial pathogen Clostridium difficile suggested that these components are dispensable for σG activity. In this study, we investigated the requirements of the SpoIIQ and SpoIIIA proteins during C. difficile sporulation. C. difficile spoIIQ, spoIIIA, and spoIIIAH mutants exhibited defects in engulfment, tethering of coat to the forespore, and heat-resistant spore formation, even though they activate σG at wildtype levels. Although the spoIIQ, spoIIIA, and spoIIIAH mutants were defective in engulfment, metabolic labeling studies revealed that they nevertheless actively transformed the peptidoglycan at the leading edge of engulfment. In vitro pull-down assays further demonstrated that C. difficile SpoIIQ directly interacts with SpoIIIAH. Interestingly, mutation of the conserved Walker A ATP binding motif, but not the Walker B ATP hydrolysis motif, disrupted SpoIIIAA function during C. difficile spore formation. This finding contrasts with B. subtilis, which requires both Walker A and B motifs for SpoIIIAA function. Taken together, our findings suggest that inhibiting SpoIIQ, SpoIIIAA, or SpoIIIAH function could prevent the formation of infectious C. difficile spores and thus disease transmission.

Indexed as

Adenosine TriphosphateAmino Acid MotifsBacterial ProteinsCell DifferentiationCell WallClostridioides difficileEnterocolitis, PseudomembranousMutationProtein BindingSigma FactorSpores, BacterialAdenosine TriphosphateBacterial ProteinsSigma Factor

Identifiers

PMID26465937
PMCPMC4605598
OpenAlexW2293426014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.